Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded
- Contract number
- SPE2DB26FSLD6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,071
Award facts
- Contract value 100% obligated
- $20,070.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,070.70 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 mcg inhalers (12 grams) under firm fixed price terms. This non-set-aside competitive award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The current award for Advair HFA inhalers reflects the company's established role in fulfilling respiratory and specialty pharmaceutical needs within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FSLD6?
SPE2DB26FSLD6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FSLD6 worth?
The government has obligated $20,071 on SPE2DB26FSLD6.
Is contract SPE2DB26FSLD6 an order under another contract?
Yes. SPE2DB26FSLD6 is a delivery order under SPE2DB20D7061, an indefinite delivery contract.
Was contract SPE2DB26FSLD6 competed?
The extent of competition for SPE2DB26FSLD6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award